Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026
JAZZJazz Pharmaceuticals(JAZZ) Prnewswire·2024-07-22 19:45

DUBLIN, July 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") today announced that it has completed a repricing of the approximately 2.7billionoutstandingbalanceofitsU.S.dollartermloansunderitscreditfacility.TheapplicablemarginaboveTermSOFRwillbereducedby75basispoints(from300basispointsto225basispoints)andthecreditspreadadjustmentwillberemoved,resultinginanticipatedinterestsavingsofapproximately2.7 billion outstanding balance of its U.S. dollar term loans under its credit facility. The applicable margin above Term SOFR will be reduced by 75 basis points (from 300 basis points to 225 basis points) and the credit spread adjustment will be removed, resulting in anticipated interest savings of approximately 23 million on an annu ...